Kolexia
Valantin Marc-Antoine
Médecine générale
Hôpital Pitie Salpetriere
Paris, France
212 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Hépatite C Hépatite Co-infection Hépatite C chronique Fibrose Cirrhose du foie Virémie COVID-19

Industries

Gilead
10 collaboration(s)
Dernière en 2023
ViiV Healthcare
10 collaboration(s)
Dernière en 2023
MSD
8 collaboration(s)
Dernière en 2023
Theratechnologies International Limited
2 collaboration(s)
Dernière en 2021

Dernières activités

Dataids_PEC: Dataids Prospective Observational Cohort on Quality of Care of French HIV Infected Patients
Essai Clinique (DatAids)   26 février 2024
Dolutegravir/rilpivirine (DTG/RPV) therapy as a maintenance treatment in PLWH with past virological failures and resistance-associated mutations to NNRTIs and INSTIs
HIV medicine Congress 2023   01 décembre 2023
Real life Cabotegravir (CAB) and Rilpivirine (RPV) pharmacokinetics among PLHIV treated with CAB RPV Long Acting (LA IM)
HIV medicine Congress 2023   01 décembre 2023
HIV-aviremic PLHIV with Kaposi's Sarcoma (KS) are prone to KS relapses and chemotherapy failure and toxicities: results from the French CancerVIH Network
HIV medicine Congress 2023   01 décembre 2023
Evolution of patterns and cost of antiretroviral strategies over 8 years among people living with HIV (PHIV): Experience of Pitié-Salpêtrière HIV clinical center in France
HIV medicine Congress 2023   01 décembre 2023
Unlocking antiretroviral treatment potential: Use of doravirine (DOR) in PLHIV with past NNRTI resistance associated mutations (RAMs)
HIV medicine Congress 2023   01 décembre 2023
BuleDelta: Observatory of Efficacy and Safety of Bulevirtide in Patients With Chronic Hepatitis B Virus (HBV)/Hepatitis D Virus (HDV) Co-infection With Severe Fibrosis Injuries, or Moderate Fibrosis Injuries Associated With Persistent Increase of ALT
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   18 août 2023
CO13Hepavih: Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With Hepatitis C and Human Immunodeficiency Virus (Collaboration Inter Cohortes et Centres Cliniques de Sujets Co-infectés Par Les Virus de l'immunodéficence Humaine et de l'hépatite C)
Essai Clinique (Merck-Serono)   01 août 2023
Intermittent doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) maintains a high level of viral suppression in virologically suppressed people living with HIV.
Infectious diseases now   14 juin 2023
Hepatitis A, hepatitis B and HPV vaccine needs and coverage in MSM initiating HIV PrEP in a sexual health clinic in Paris.
Sexually transmitted infections   12 mai 2023